High incidence of venous thromboembolism and major bleeding in patients with primary CNS lymphoma

References

• Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985–1999. Neuro-oncology. 2006;8(1):27–37.
   PubMed Web of Science ®Google Scholar
• Mahajan A, Wun T, Chew H, et al. Lymphoma and venous thromboembolism: influence on mortality. Thromb Res. 2014;133(Suppl. 2):S23–S28.
   PubMedGoogle Scholar
• Falanga A, Marchetti M. Venous thromboembolism in the hematologic malignancies. J Clin Oncol. 2009;27(29):4848–4857.
   PubMed Web of Science ®Google Scholar
• Semrad TJ, O'Donnell R, Wun T, et al. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg. 2007;106(4):601–608.
   PubMed Web of Science ®Google Scholar
• Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer. 2000;89(3):640–646.
   PubMed Web of Science ®Google Scholar
• Brandes AA, Scelzi E, Salmistraro G, et al. Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study. Eur J Cancer. 1997;33(10):1592–1596.
   PubMed Web of Science ®Google Scholar
• Goldschmidt N, Linetsky E, Shalom E, et al. High incidence of thromboembolism in patients with central nervous system lymphoma. Cancer. 2003;98(6):1239–1242.
   PubMed Web of Science ®Google Scholar
• Ravi G, Cooper B, Campagnaro EL, et al. Increased risk of venous thromboembolism in primary central nervous system lymphoma patients undergoing therapy. Blood. 2014;124(21):5431.
   Web of Science ®Google Scholar
• Mahajan A, Ho S, Lo M, et al. Frequency, risk factors and mortality effect of venous thromboembolism in adult patients with central nervous system lymphoma. Blood. 2015;126(23):4458.
   Web of Science ®Google Scholar
• White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123(Suppl. 4):S11–S17.
   PubMedGoogle Scholar
• Byun JM, Hong J, Yoon SS, et al. Incidence and characteristics of venous thromboembolism in Asian patients with primary central nervous system lymphoma undergoing chemotherapy. Thromb Res. 2019;183:131–135.
   PubMed Web of Science ®Google Scholar
• Villano JL, Koshy M, Shaikh H, et al. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer. 2011;105(9):1414–1418.
   PubMed Web of Science ®Google Scholar
• Tao L, Foran JM, Clarke CA, et al. Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era. Blood. 2014;123(23):3553–3562.
   PubMed Web of Science ®Google Scholar
• Yost K, Perkins C, Cohen R, et al. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12(8):703–711.
   PubMed Web of Science ®Google Scholar
• White RH, Garcia M, Sadeghi B, et al. Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thromb Res. 2010;126(1):61–67.
   PubMed Web of Science ®Google Scholar
• Fang MC, Go AS, Chang Y, et al. A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011;58(4):395–401.
   PubMed Web of Science ®Google Scholar
• Schoenman JA, Sutton JP, Elixhauser A, et al. Understanding and enhancing the value of hospital discharge data. Med Care Res Rev. 2007;64(4):449–468.
   PubMed Web of Science ®Google Scholar
• Clark TG, Bradburn MJ, Love SB, et al. Survival analysis part I: basic concepts and first analyses. Br J Cancer. 2003;89(2):232–238.
   PubMed Web of Science ®Google Scholar
• Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17(4):343–346.
   PubMedGoogle Scholar
• Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601–609.
   PubMed Web of Science ®Google Scholar
• Levesque LE, Hanley JA, Kezouh A, et al. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340:b5087.
   PubMed Web of Science ®Google Scholar
• Liu J, Weinhandl ED, Gilbertson DT, et al. Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies. Kidney Int. 2012;81(4):341–350.
   PubMed Web of Science ®Google Scholar
• Giobbie-Hurder A, Gelber RD, Regan MM. Challenges of guarantee-time bias. J Clin Oncol. 2013;31(23):2963–2969.
   PubMed Web of Science ®Google Scholar
• Allison PD. Survival analysis using SAS: a practical guide. 2nd ed. Cary, NC: SAS Institute Inc; 2010.
   Google Scholar
• Brunson AK, Mahajan A, White RH, et al. Cancer associated venous thromboembolism: incidence and impact on survival. International Conference on Thrombosis and Hemostasis Issues in Cancer; Bergamo, Italy; 2018.
   Google Scholar
• Wakai S, Yamakawa K, Manaka S, et al. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery. 1982;10(4):437–444.
   PubMed Web of Science ®Google Scholar
• Mantia C, Uhlmann EJ, Puligandla M, et al. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Blood. 2017;129(25):3379–3385.
   PubMed Web of Science ®Google Scholar
• Zwicker JI, Karp Leaf R, Carrier M. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. J Thromb Haemost. 2016;14(9):1736–1740.
   PubMed Web of Science ®Google Scholar
• Perry JR, Julian JA, Laperriere NJ, et al. PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost. 2010;8(9):1959–1965.
   PubMed Web of Science ®Google Scholar
• Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006;166(4):458–464.
   PubMed Web of Science ®Google Scholar
• Poudel SK, Park DY, Jia X, et al. Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: the Cleveland Clinic Experience. J Thromb Haemost. 2020;18(3):651–659.
   PubMed Web of Science ®Google Scholar